Filgrastim Completed Phase 2 Trials for Peripheral T-Cell Lymphoma (PTCL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00791947A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT